The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a ...

We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the NHI to find out what we can expect — and ...

How to lose weight in 2026 with the new Wegovy pill. Also in this month’s Your Health column: Is the super flu a real thing; ...

A recent study revealed that popular GLP-1 weight-loss drugs may significantly minimise severe asthma attacks among teenagers ...

Explore the most influential drug approvals of 2025, highlighting FDA-cleared therapies that impact public health and clinical care.

Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...

For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

United States ranked well below nine other thriving countries by a large margin (per The Commonwealth Fund) in health ...

The new year could bring dramatic changes to health care. Michigan doctors highlight the top 5 things they expect to see in ...

In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, the first ...

When a staggeringly slender Emily Atack posted pictures of her family's Christmas, the last thing she would have expected ...

We’ll say goodbye to international med students and hello to mumps. Governments, meanwhile, will clear patient backlogs with ...